| Alliance HealthCare Services Reports Results for the First Quarter Ended March 31, 2010 and Reaffirms Full Year 2010 Guidance (Business Wire) NEWPORT BEACH, Calif.----Alliance HealthCare Services, Inc. , a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced results for the first quarter ended March 31, 2010. us.rd.yahoo.com |
Genoptix Provides First Look at Second Quarter Results and Updates 2010 Guidance (PR Newswire) Genoptix, Inc. , a specialized laboratory services provider, today provided a first look at performance for the second quarter of 2010 and announced an update to annual guidance expectations for full-year 2010.  us.rd.yahoo.com |
ERT to Announce Second Quarter 2010 Results on August 9, 2010 (PR Newswire) ERT announced today that it will release its results for the second quarter 2010 on Monday, August 9, 2010, after the market closes. After the release, the Company will host a conference call at 5:00 PM EDT that day. us.rd.yahoo.com |
Axial Capital Can't Get Enough of QLT Market Folly submits:Hedge fund Axial Capital Management seems to have an insatiable appetite for shares of QLT Inc (QLTI) at current levels. Eliav Assouline and Marc Andersen's hedge fund firm has made the following acquisitions according to multiple SEC Form 4 filings:August 26th: 50,000 shares @ $5.67August 27th: 50,000 shares @ $5.78August 30th: 7,400 shares @ $5.70August 31st: 60,506 shares @ $5.75September 1st: 5,318 shares @ $5.75Complete Story » seekingalpha.com |
Novartis Beats Merck in Race for Approval of First Oral MS Pill The Burrill Report submits: By Michael FitzhughGilenya has become the first oral multiple sclerosis pill capable of slowing the disease's progression and reducing relapses to win approval from the U.S. Food and Drug Administration. Novartis (NVS), developer of the drug, beat Merck's (MKGAY.PK) late-stage oral treatment cladribine to U.S. approval and could generate $1 billion in annual sales or more, according to both industry analysts and Novartis. Complete Story » seekingalpha.com |